Alexandra Glucksmann
Chief Operating Officer, Editas Medicine.
Companies
- REGENXBIO Inc.Board member May 30, 2018 to now1
- Editas MedicineChief operating officer Feb 2, 2016 to Mar 17, 20172
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- REGENXBIO Inc. RGNX28,861 shares3$206.8K at $7.17May 29, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 29, 2026Granted 9,807 shares of REGENXBIO Inc.3
- May 30, 2025Granted 7,768 shares of REGENXBIO Inc.4
- May 31, 2024Granted 4,790 shares of REGENXBIO Inc.5
- Jun 2, 2023Granted 3,486 shares of REGENXBIO Inc.6
- Jun 3, 2022Granted 3,010 shares of REGENXBIO Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARREGENXBIO Inc., Board member
- 2
- 3
- 4SEC EDGARForm 4 filed Jun 3, 2025
- 5SEC EDGARForm 4 filed Jun 4, 2024
- 6SEC EDGARForm 4 filed Jun 6, 2023
- 7SEC EDGARForm 4 filed Jun 7, 2022